Author Chung, Inn
-
2010 | Journal Article | Research Paper
Three-dimensional organization of promyelocytic leukemia nuclear bodies
Lang, M. C.; Jegou, T.; Chung, I.; Richter, K.; Münch, S.; Udvarhelyi, A. & Cremer, C. et al. (2010)
Journal of Cell Science, 123(3) pp. 392-400. DOI: https://doi.org/10.1242/jcs.053496
Details DOI PMID PMC WoS
-
2020 | Journal Article |
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
von Eiff, D.; Bozorgmehr, F.; Chung, I.; Bernhardt, D.; Rieken, S. ; Liersch, S. & Muley, T. et al. (2020)
Journal of Thoracic Disease, 12(3) pp. 782-793. DOI: https://doi.org/10.21037/jtd.2019.12.74
Details DOI PMID PMC
-
2020 | Journal Article |
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
Bozorgmehr, F.; Chung, I.; Christopoulos, P.; Krisam, J.; Schneider, M. A.; Brückner, L. & Mueller, D. W. et al. (2020)
BMC Cancer, 20(1). DOI: https://doi.org/10.1186/s12885-020-07264-8
Details DOI
-
2021 | Journal Article
De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer
Bozorgmehr, F.; Kazdal, D.; Chung, I.; Kirchner, M.; Magios, N.; Kriegsmann, M. & Allgäuer, M. et al. (2021)
Frontiers in Oncology, 11 art. 640048. DOI: https://doi.org/10.3389/fonc.2021.640048
Details DOI PMID PMC
-
2022 | Journal Article | Research Paper |
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial
Bozorgmehr, F.; Christopoulos, P.; Chung, I.; Cvetkovic, J.; Feißt, M.; Krisam, J. & Schneider, M. A. et al. (2022)
BMC Cancer, 22(1) art. 1011. DOI: https://doi.org/10.1186/s12885-022-10074-9
Details DOI
-
2023 | Journal Article | Erratum
Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
Bozorgmehr, F.; Chung, I.; Christopoulos, P.; Krisam, J.; Schneider, M. A.; Brückner, L. & Mueller, D. W. et al. (2023)
BMC Cancer, 23(1). DOI: https://doi.org/10.1186/s12885-023-11270-x
Details DOI